Intellicheck Reports Third Quarter 2026 Results

Intellicheck, Inc. (IDN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Intellicheck Reports Third Quarter 2026 Results Net Income Rises to $0.5 Million Adjusted EBITDA Increases to $0.9 Million Cash Balance Grows to $13.2 Million, Highest Level Since the End of 2021, with No Debt MELVILLE, NEW YORK – November 12, 2026 – Intellicheck, Inc. (Nasdaq: I

Original reporting
Published Nov 12, 2026, 9:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$IDN
Neutral
high confidence
Mentioned
$IDN
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$IDNNeutralMed
01

Why it matters

The earnings release provides fresh data on profitability and cash, offering a basis for short‑term trading decisions.

02

Market read

First‑time disclosure of Q3 earnings for a micro‑cap; modest trading relevance.

03

What to watch

Potential future growth from new channel partnerships in wealth management and automotive credit.

Relevance 7/10Novelty 7/10Timing: after-hours release

Background

Intellicheck (Nasdaq: IDN) filed a Form 8‑K reporting its third‑quarter 2026 financial results.

Company-level read

Ticker impact

$IDNNeutralHigh confidence
Context

Q3 2026 results show net income of $0.5M, adjusted EBITDA of $0.9M and cash of $13.2M, with revenue down 5% YoY.

Expected impact

modest upside as investors price in continued profitability and strong cash position

Evidence & confidence

Positive earnings and cash balance offset modest revenue decline; market may view the results as a sign of resilience.

Market effects

Signals strength in identity‑verification SaaS sector, may support peers with similar business models.

Limited to US tech micro‑cap space; no broad regional effect.

Low global relevance; primarily impacts niche identity‑verification market.

Counterpoint

Revenue decline could indicate slowing demand; stock may face pressure despite profitability.

Key entities

  • Intellicheck, Inc.

    Identity verification SaaS provider reporting Q3 2026 results.

Related articles

$IDNMed

Intellicheck Reports Second Quarter 2026 Results

Intellicheck, Inc. (IDN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Intellicheck Reports Second Quarter 2026 Results Revenue Grows 16% to $5.9 Million Net Income Rises to $0.7 Million Adjusted EBITDA Increases to $1.1 Million MELVILLE, NEW YORK – August 13, 2026 – Intellicheck, Inc. (Nasdaq: IDN) (“Intellicheck” or the “Company”), an industry-lea

$NOKMed

LightCounting:: November 2026 Nokia SReXperts

Nokia hosted its SReXperts/Wavelengths conference in November 2026, focusing on AI's impact on connectivity and its solutions for customers. The company reported strong Q3 2026 earnings, with AI & Cloud sales doubling year-over-year and $1.7 billion in new orders. Nokia expects 25-30% growth in its Optical and IP Networks businesses in 2027. The company aims to help telecom operators adapt to AI-driven changes and capitalize on new opportunities.

$IBRXLow

IBRX Stock Eyes Best Year Ever: Founder Teases 12 Months Of ‘Stealth’ NantWorks Reveals — Cancer Tech, AI Chips And Satellites

ImmunityBio (IBRX) reported a 53% increase in Q3 net product revenue to $48.7M, with 92% growth for the first nine months. The company is testing its drug Anktiva for sepsis and aims to expand FDA approval for bladder cancer. NantWorks, led by Patrick Soon-Shiong, plans a blockchain-based exchange for tokenized securities. IBRX stock has risen 195% over the past year, with bullish retail sentiment on Stocktwits.